Trading Statement
Aspen Pharmacare Holdings Limited
(Incorporated in the Republic of South Africa)
(Registration number 1985/002935/06)
Share code: APN & ISIN: ZAE000066692
("Aspen")
Trading Statement
Aspen shareholders are hereby advised that normalised headline earnings per share
(“NHEPS”), headline earnings per share and earnings per share for the year ended 30
June 2017 are expected to improve on those reported in the prior year, ended 30 June
2016, within the following ranges:
Measure Range Cents per share Cents per share in Notes
the prior year -
30 June 2016
NHEPS 13% to 18% 1428.0 to 1491.2 1263.7 1
Headline earnings per 43% to 48% 1271.3 to 1315.7 889.0 2
share
Earnings per share 16% to 21% 1096.7 to 1143.9 945.4 3
Notes:
1. NHEPS comprises headline earnings per share adjusted for specific non-trading items.
NHEPS is the primary measure used by management to assess Aspen’s underlying
financial performance.
2. The significant increase in headline earnings per share is attributable to the
devaluation of Aspen’s Venezuelan business in the prior year.
3. The increase in earnings per share has been influenced by the following factors which
negatively affected the prior year’s performance:
- the devaluation of Aspen’s Venezuelan business; and
- higher intangible asset impairments;
- offset by significant capital profits realised from the disposal of non-core businesses
and products.
The financial results on which this trading announcement is based have not been reviewed
or reported on by Aspen’s external auditors.
Aspen’s results for the year months ended 30 June 2017 are scheduled to be published
on SENS on 14 September 2017.
Durban
30 August 2017
Sponsor: Investec Bank Limited
Date: 30/08/2017 02:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.